By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nabriva Therapeutics 

Leberstrasse 20

Vienna    1112  Austria
Phone: 43-0-1-74093-0 Fax: 43-0-1-74093-1900


Company News
Nabriva Reports Second Quarter 2017 Financial Results And Recent Corporate Highlights 8/7/2017 12:07:01 PM
Nabriva Appoints Francesco Maria Lavino As Chief Commercial Officer 7/11/2017 10:44:16 AM
Nabriva Appoints Carrie Bourdow And Colin Broom To The Board 6/26/2017 11:23:42 AM
Nabriva Announces Webcast Of Analyst & Investor Day On June 19, 2017 6/5/2017 1:34:07 PM
Nabriva To Present Data At ASM Microbe Supporting Ongoing Phase III Clinical Development Program For Lefamulin 6/2/2017 9:01:49 AM
Nabriva Commences Previously Announced Tender Offer Related To The Proposed Redomicile Of Its Holding Company From Austria To Ireland 5/23/2017 11:08:05 AM
Nabriva Reports First Quarter 2017 Financial Results 5/11/2017 11:48:14 AM
Nabriva Announces The Proposed Redomicile Of Its Holding Company From Austria To Ireland, By Means Of An Exchange Offer 4/17/2017 8:23:39 AM
Nabriva Announces Enrollment Completion For LEAP 1, A Phase III Clinical Trial Evaluating Lefamulin In Community-Acquired Bacterial Pneumonia 4/11/2017 10:09:36 AM
Nabriva Provides Business And Development Update And Reports 2016 Financial Results 3/27/2017 8:17:47 AM